SynthesisEuropean radiology2025
Intracranial atherosclerotic plaque features on vessel wall imaging predict first ever and recurrence of stroke: a meta-analysis.
Synthesis in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Beyond plaque morphology: a multimodal imaging model combining structural vulnerability and functional reserve predicts stroke recurrence in symptomatic intracranial atherosclerosis.Quantitative imaging in medicine and surgery · 2026Article
- Editorial for "Intracranial Plaque Characteristics and Extracranial Carotid Plaque-RADS Associated With Stroke Recurrence: A High-Resolution Vessel Wall Imaging Study".Journal of magnetic resonance imaging : JMRI · 2026Article
- Association and Risk-Stratification Value of the Positive Remodeling Index of Middle Cerebral Artery Atherosclerotic Plaques for Perforator-Territory Infarction Based on High-Resolution Magnetic Resonance Imaging.Revista de neurologia · 2026Article
- Expert consensus on intracranial vessel wall MRI in cerebrovascular disease: Society for Magnetic Resonance Angiography recommendations.European radiology · 2026Review
- Cerebral Infarction: Epidemiology, Classification, Mechanisms, Diagnosis, and Management.MedComm · 2026Review
- Vertebrobasilar artery geometry and quantitative high-resolution vessel wall MRI for stratifying vulnerable plaques in young and middle-aged adults with stroke risk factors.Frontiers in medicine · 2026Article
- Endovascular Therapy for Intracranial Atherosclerotic Stenosis: Evidence and Controversies.Journal of neuroendovascular therapy · 2026Review
- The triglyceride-glucose index: updating evidence from clinical settings to molecular mechanisms in ageing-related cerebrovascular diseases.Cardiovascular diabetology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesIntracranial atherosclerotic disease (ICAD) features on vessel wall magnetic resonance imaging (VW-MRI) are associated with first-ever or recurrent ischemic stroke (IS) or transient ischemic attack (TIA). There are multiple longitudinal ICAD VW-MRI studies, but they are limited by small sample size, non-standardized imaging acquisition and analysis, and some controversial results. Hence, we conducted the current meta-analysis of intracranial plaque features predicting recurrence of IS. MATERIALS AND
methodsPubMed, Web of Science, and EMBASE databases were searched through March 2024. Two independent reviewers extracted data on study design, VW-MRI techniques, and patient outcome. Quality assessment was used by the NOS tool. Subgroup analyses, sensitivity analysis, and evaluation of publication bias were also performed.
resultsFor recurrent IS, eighteen studies were included for meta-analysis, comprising 2240 participants, and 472 participants had recurrent IS during an average of 16-month follow-up. All studies were of high quality with an NOS score ≥ 7. Plaque enhancement (OR 2.18, [95% CI 1.70-4.65]), plaque enhancement ratio (SMD 0.46, [95% CI 0.15-0.77]), plaque thickness, (SMD 0.271, [95% CI 0.047-0.496]), T1-weighted (T1W) hyperintensity, (OR 2.58, [95% CI 1.56-4.26]), and degree of stenosis (SMD 0.41, [95% CI 0.03-0.79]) significantly predicted IS recurrence. Subgroup analyses found plaque enhancement was significantly higher in the IS and TIA recurrence group as compared to the non-recurrence group (OR 3.39, 95% CI 1.84-6.22).
conclusionPlaque enhancement, plaque enhancement ratio, plaque thickness, T1W hyperintensity and degree of stenosis emerged as strong imaging biomarkers of recurrence of stroke. CLINICAL
trial registrationClinical trial registration no: CRD42023479678. KEY POINTS: Questions Several studies suggest that vessel wall MRI (VWMRI) features of intracranial atherosclerotic disease (ICAD) may be associated with first-time or recurrent ischemic strokes, though this remains a debated topic. Findings Our study demonstrates that plaque enhancement, plaque enhancement ratio, plaque thickness, T1W hyperintensity, and degree of stenosis are strong imaging biomarkers for predicting stroke recurrence. Clinical relevance Incorporating these features into post-stroke evaluations using VWMRI could help guide patient management more effectively, enabling more targeted treatments for secondary stroke prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.